Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,383.86
+400.46(+0.80%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

China Shineway Pharmaceutical Group Limited (CSWYY)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

24.32

0.00

(0.00%)

At close: 09:30AM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	984.25M
Enterprise value	209.79M
Trailing P/E	6.88
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	1.47
Price/book (mrq)	1.04
Enterprise value/revenue	0.05
Enterprise value/EBITDA	0.15

Trading information

Stock price history

Beta (5Y monthly)	0.81
52-week change ³	29.36%
S&P500 52-week change ³	22.38%
52-week high ³	27.85
52-week low ³	18.80
50-day moving average ³	24.02
200-day moving average ³	20.10

Share statistics

Avg vol (3-month) ³	41
Avg vol (10-day) ³	18
Shares outstanding ⁵	41.35M
Implied shares outstanding ⁶	48.43M
Float ⁸	207.04M
% held by insiders ¹	N/A
% held by institutions ¹	N/A
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	1.48
Forward annual dividend yield ⁴	6.08%
Trailing annual dividend rate ³	0.42
Trailing annual dividend yield ³	1.73%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	32.90%
Dividend date ³	03 Jun 2024
Ex-dividend date ⁴	29 Apr 2024
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	21.47%
Operating margin (ttm)	18.14%

Management effectiveness

Return on assets (ttm)	6.81%
Return on equity (ttm)	14.45%

Income statement

Revenue (ttm)	4.52B
Revenue per share (ttm)	119.58
Quarterly revenue growth (yoy)	-0.80%
Gross profit (ttm)	N/A
EBITDA	1.14B
Net income avi to common (ttm)	969.51M
Diluted EPS (ttm)	3.54
Quarterly earnings growth (yoy)	22.10%

Balance sheet

Total cash (mrq)	5.91B
Total cash per share (mrq)	7.83
Total debt (mrq)	301.33M
Total debt/equity (mrq)	4.28%
Current ratio (mrq)	3.35
Book value per share (mrq)	9.31

Cash flow statement

Operating cash flow (ttm)	932.64M
Levered free cash flow (ttm)	601.34M